Related Experiment Video
Updated: Jun 10, 2026
07:00
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
Published on: September 26, 2016
New approaches to treating and preventing bone metastases
1Department of Medicine, Division of Hematology/Oncology, MS Hershey Medical Center of the Pennsylvania State University, Hershey, Pennsylvania 17033, USA. alipton@hmc.psu.edu
Current Opinion in Supportive and Palliative Care
|August 13, 2010
Summary
New bone-directed therapies show promise in treating and preventing cancer bone metastases, potentially improving patient quality of life. Research is exploring novel treatments beyond bisphosphonates to combat skeletal and extraskeletal spread.
Area of Science:
- Oncology
- Bone Metastasis Research
Background:
- Bone metastases represent a significant clinical challenge in cancer care.
- Maintaining quality of life for patients with metastatic bone disease is a critical unmet need.
Purpose of the Study:
- To review novel therapeutic strategies for the treatment and prevention of bone metastases.
- To explore the potential of bone-directed therapies in preventing both skeletal and extraskeletal metastases.
Main Methods:
- Review of current literature on bone metastasis treatment and prevention.
- Discussion of emerging therapies and ongoing clinical trials.
Main Results:
- Intravenous bisphosphonates have been the standard treatment for bone metastases for the past decade.
- New therapies, including the RANKL antibody denosumab, are in late-stage clinical development.
- Emerging evidence suggests bisphosphonates may prevent metastatic disease progression.
Conclusions:
- Advances in understanding bone metastasis biology have revealed numerous potential new therapeutic targets.
- Several promising novel approaches for managing bone metastases are discussed, offering hope for improved patient outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...